title: Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapy.
authors.affiliation: Clinical Laboratory Science, Genzyme Corporation, One Mountain Road, Framingham, MA 01701-9322, USA.
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Roddy
authors.forename: Bryant C
authors.initials: BC
authors.lastname: Nelson
authors.forename: Crystal C C
authors.initials: CC
authors.lastname: Sung
authors.forename: Shaparak
authors.initials: S
authors.lastname: Araghi
authors.forename: Dennis
authors.initials: D
authors.lastname: Wilkens
authors.forename: X Kate
authors.initials: XK
authors.lastname: Zhang
authors.forename: John J
authors.initials: JJ
authors.lastname: Thomas
authors.forename: Susan M
authors.initials: SM
authors.lastname: Richards
mesh_terms: D002853:Chromatography, Liquid; D000795:Fabry Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000627:therapeutic use*; D008297:Male; D013058:Mass Spectrometry; D008991:Monitoring, Physiologic; D014281:Trihexosylceramides / Q000097:blood*; D000519:alpha-Galactosidase / Q000627:therapeutic use*
chemical_list: D007527:Isoenzymes; D014281:Trihexosylceramides; C018549:globotriaosylceramide; D000519:alpha-Galactosidase; C459420:agalsidase beta